News & Media
September 16, 2021
Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing
The number of gene therapy candidates in development is growing rapidly, with many advancing toward late-stage trials. The majority of...
August 23, 2021
Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances
Abstract: Andelyn Biosciences, a full-spectrum gene therapy CDMO organization that supports clients from preclinical studies through phase III trials, originally...
June 20, 2021
AAV Vector Manufacturing
Adeno-associated viruses (AAV) are small viruses that can infect humans and other primate species. The particularity about AAV is that...
February 15, 2021
The Andelyn Difference
“What’s in a name?” the saying goes. In this case, much more than meets the eye. Andelyn Biosciences is much...
November 15, 2020
Manufacturing of Viral Vectors for Gene Therapy
Viral vectors are an essential part of gene therapy treatments. They are essential for delivering corrected genetic information to faulty...
September 15, 2020
Insights On Cell and Gene Therapy Manufacturing
Gene therapy has revolutionized medicine since the early 1990s and is one of the most promising fields in medicine. In...
July 20, 2020
Understanding The 5 Elements Of cGMP
Current Good Manufacturing Processes (cGMP) are outlined by the FDA, which defines them as the “minimum requirements for the methods,...
April 15, 2020
Understanding The Gene Therapy Manufacturing Process
Gene therapy is the process of replacing damaged or unhealthy genetic material with new material for treating various diseases and...